This information is intended for residents of the United States of America.

Could your child’s
psoriasis
align with PROTOSTAR research?

Learn how your child could take part in the PROTOSTAR study for children and adolescents with chronic plaque psoriasis.

This information is intended for residents of the United States of America.

Could your child’s
psoriasisalign with PROTOSTAR research?

Learn how your child could take part in the PROTOSTAR study for children and adolescents with chronic plaque psoriasis.

Does my child qualify for this study?
Find out if your child could be eligible for participation in this study.

Learn More

Could your child’s psoriasis align with PROTOSTAR research?

Learn how your child could take part in the PROTOSTAR study for children and adolescents with chronic plaque psoriasis.

Doctors with the PROTOSTAR study want to learn more about an investigational study medication for children who have been diagnosed with chronic plaque psoriasis. Through PROTOSTAR, they hope to understand more about the safety and effectiveness of the investigational study medication in children.

The investigational study medication has been approved for adults in the United States and other countries. However, it has not been approved for children with chronic plaque psoriasis. As a result, it is considered investigational for use in children and only available in research studies.

This study will help provide more information about the safety and effectiveness of the investigational study medication on children with chronic plaque psoriasis.

If your child participates in this study, he or she will receive all study-required visits, tests, and investigational study medication at no cost.

For more information about this study, please click here.

Does my child qualify for this study?
Find out if your child could be eligible for participation in this study.

Learn More